Opiant Announces Publication of Manuscript Treatment of Overdose in the Synthetic Opioid Era in Peer-Reviewed Journal Pharmacology & Therapeutics

Got To Article
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a company advancing medicines to better treat addictions and drug overdose, today announced the publication of a manuscript entitled “Treatment of Overdose in the Synthetic Opioid Era” authored by Phil Skolnick,
0 comments

The Beachbody Company Appoints Jean-Michel Fournier to Lead Global Partnership and International Development Efforts

Got To Article
The Beachbody Company, Inc. (NYSE: BODY) (“Beachbody” or the “Company”), a leading subscription health and wellness company, today announced that Jean-Michel Fournier will assume the newly created role of President,
0 comments

Innovative Webinar Series Developed by Top Mental Health Treatment Provider Helps Schools & Professionals Tackle Teen Mental Health National Emergency

Got To Article
An innovative webinar series kicks off today to support mental health and school professionals with education and training on prevalent teen mental health issues. The complimentary, live sessions will address our nation’s current crisis,
0 comments

Empirical Spine Presents Data From Study of the LimiFlex™ Tension Band at the Society for ...

Got To Article
Empirical Spine, Inc., a Silicon-Valley based medical technology company, announced today that data from the IDE study of the company’s LimiFlex Tension Band for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis,
0 comments